Technical Analysis for PSTX - Poseida Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Expansion Breakout | Bullish Swing Setup | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
Stochastic Reached Overbought | Strength | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% |
Alert | Time |
---|---|
Possible Pocket Pivot | about 13 hours ago |
60 Minute Opening Range Breakout | about 14 hours ago |
2x Volume Pace | about 15 hours ago |
1.5x Volume Pace | about 15 hours ago |
Up 2 ATRs | about 15 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/14/2024
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Solid Tumors Immune System Cancer Treatment Lymphoma Leukemia Chimeric Antigen Receptor T Cell Hematological Malignancies Chimeric Antigen Receptor Cellectis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Solid Tumors Immune System Cancer Treatment Lymphoma Leukemia Chimeric Antigen Receptor T Cell Hematological Malignancies Chimeric Antigen Receptor Cellectis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.27 |
52 Week Low | 1.54 |
Average Volume | 746,021 |
200-Day Moving Average | 2.74 |
50-Day Moving Average | 2.83 |
20-Day Moving Average | 2.54 |
10-Day Moving Average | 2.87 |
Average True Range | 0.24 |
RSI (14) | 69.14 |
ADX | 24.24 |
+DI | 39.54 |
-DI | 15.49 |
Chandelier Exit (Long, 3 ATRs) | 2.81 |
Chandelier Exit (Short, 3 ATRs) | 2.60 |
Upper Bollinger Bands | 3.33 |
Lower Bollinger Band | 1.75 |
Percent B (%b) | 1.08 |
BandWidth | 62.36 |
MACD Line | 0.09 |
MACD Signal Line | -0.02 |
MACD Histogram | 0.1031 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.33 | ||||
Resistance 3 (R3) | 4.26 | 3.90 | 4.19 | ||
Resistance 2 (R2) | 3.90 | 3.68 | 3.94 | 4.14 | |
Resistance 1 (R1) | 3.68 | 3.54 | 3.79 | 3.75 | 4.09 |
Pivot Point | 3.32 | 3.32 | 3.38 | 3.36 | 3.32 |
Support 1 (S1) | 3.10 | 3.10 | 3.21 | 3.17 | 2.83 |
Support 2 (S2) | 2.74 | 2.96 | 2.78 | 2.78 | |
Support 3 (S3) | 2.52 | 2.74 | 2.74 | ||
Support 4 (S4) | 2.59 |